Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders
Sponsor: Mclean Hospital
A PHASE2 clinical study on Bipolar I Disorder and Psychosis, this trial is completed. The trial is conducted by Mclean Hospital and has accumulated 15 data snapshots since 2019. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
15 versions recorded-
May 2025 — Present [monthly]
Completed PHASE2
Status: Recruiting → Completed
-
Sep 2024 — May 2025 [monthly]
Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2
-
Jan 2024 — Jul 2024 [monthly]
Recruiting PHASE2
-
Nov 2023 — Jan 2024 [monthly]
Recruiting PHASE2
▶ Show 10 earlier versions
-
Aug 2023 — Nov 2023 [monthly]
Recruiting PHASE2
-
Jun 2023 — Aug 2023 [monthly]
Recruiting PHASE2
-
Sep 2022 — Jun 2023 [monthly]
Recruiting PHASE2
-
Jul 2022 — Sep 2022 [monthly]
Recruiting PHASE2
-
Jun 2021 — Jul 2022 [monthly]
Recruiting PHASE2
-
Jan 2021 — Jun 2021 [monthly]
Recruiting PHASE2
-
Jan 2020 — Jan 2021 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Oct 2019 — Jan 2020 [monthly]
Not Yet Recruiting PHASE2
-
Aug 2019 — Oct 2019 [monthly]
Not Yet Recruiting PHASE2
-
Jun 2019 — Aug 2019 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Mclean Hospital
For direct contact, visit the study record on ClinicalTrials.gov .